Towards new mechanisms: an update on therapeutics for treatment-resistant major depressive disorder.
about
Signaling pathways underlying the antidepressant-like effect of inosine in miceCyclooxygenase-2 inhibition reduces stress-induced affective pathology.The Role of Psychotropic Medications in the Management of Anorexia Nervosa: Rationale, Evidence and Future ProspectsHCN-channel dendritic targeting requires bipartite interaction with TRIP8b and regulates antidepressant-like behavioral effects.Backing into the future: pharmacological approaches to the management of resistant depressionRole of neuro-immunological factors in the pathophysiology of mood disorders.Targeting glutamate signalling in depression: progress and prospects.Ketamine for treatment-resistant depression: recent developments and clinical applications.Role of Neuro-Immunological Factors in the Pathophysiology of Mood Disorders: Implications for Novel Therapeutics for Treatment Resistant Depression.Dietary patterns and mental health after myocardial infarction.The Modulatory Properties of Chronic Antidepressant Drugs Treatment on the Brain Chemokine - Chemokine Receptor Network: A Molecular Study in an Animal Model of Depression.Immune-based strategies for mood disorders: facts and challenges.A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Comparison Design Trial of Adjunctive Riluzole for Treatment-Resistant Major Depressive Disorder.Glutamatergic system and mTOR-signaling pathway participate in the antidepressant-like effect of inosine in the tail suspension test.Pharmacological treatment of unipolar depressive disorders: summary of WFSBP guidelines.T Cell Phenotype and T Cell Receptor Repertoire in Patients with Major Depressive Disorder.Clinical Trial of the Potassium Channel Activator Diazoxide for Major Depressive Disorder Halted Due to Intolerability.
P2860
Q33689441-E07AFE2F-0227-4943-8F3F-31A63FF2C39EQ36888657-444543A1-2387-40A6-B6CA-4632F199DE4AQ36918091-69BE58C9-5EE3-4B6F-BA43-86269F468999Q37583999-B2650133-BE28-426E-873A-7E3EB0CD3ED5Q38637621-A13B72A2-68DE-4E67-A7AE-AFC5F7ED4826Q38709282-F4367246-9646-4006-80CB-548E3BDD5211Q38743867-256C875F-EC49-481D-98BA-4BE6C8C7742AQ38800172-28A1805C-45CB-4ED6-817D-C4ACD4C1D420Q38966223-08A82BED-FA7F-4AD6-BE49-8972F96CFA0DQ42696958-26B824AA-5A70-4853-B020-FA08FB6E5EEFQ47161248-371C9F3F-7351-4392-A241-72AE6514BED6Q47694934-7CBF5F08-2022-487C-A9E8-CE6ECFB69E42Q47710967-5AA7A20C-4A28-42CD-8214-6BD53B41D20EQ47831328-B1FD7D7E-3A31-4E55-A66F-7FC81CDF3AEAQ47927842-D6DA93C3-1786-447E-B87F-8D82B82968FDQ52808280-63B0114B-0771-4478-90CA-A5B3FC3F6D27Q53076446-AED8D859-8772-4338-A868-05600E28FB58
P2860
Towards new mechanisms: an update on therapeutics for treatment-resistant major depressive disorder.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Towards new mechanisms: an upd ...... ant major depressive disorder.
@en
type
label
Towards new mechanisms: an upd ...... ant major depressive disorder.
@en
prefLabel
Towards new mechanisms: an upd ...... ant major depressive disorder.
@en
P2860
P356
P1433
P1476
Towards new mechanisms: an upd ...... ant major depressive disorder.
@en
P2093
D F Ionescu
G I Papakostas
P2860
P2888
P304
P356
10.1038/MP.2015.92
P407
P577
2015-07-07T00:00:00Z
P6179
1002517231